Health Condition 1: null- Term Pregnanat Female Parturients
Conditions
Interventions
Intervention1: 10ml of Levobupivacaine 0.125% with normal saline: 10ml of Levobupivacaine 0.125% with normal saline in group I patients will be injected into the epidural space. Top up dose of 8ml con
Sponsors
Dr T S Punia
Eligibility
Inclusion criteria
Inclusion criteria: ï?? Singleton Healthy ï?? Full-term pregnancy ï?? ASA physical status I or II
Exclusion criteria
Exclusion criteria: • Breech presentations • Antepartum haemorrhage • Severe pre-eclampsia • Aortic stenosis • Cephalopelvic disproportions • Coagulation defects or on anti-coagulant therapy • Vertebral deformity • Local sepsis • Sensitivity to the drug to be administered • Fetal distress
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Onset of Analgesia â?¢ Level of Analgesia Duration of First Stage Duration of Second Stage Dose given in each Top-up Total Top-ups TotalTimepoint: outcome to be studied during and immediately after completion of study .time taken in hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Type of Delivery Normal delivery Cesarean section Instrumental delivery Complications during Analgesia in labour Nausea Vomiting Headache Backache Pruritis Urinary Retention Apgar Score of Neonate - 1 min. â?? 5 min. Any Fetal Distress Timepoint: outcome to be studied during and immediately after completion of study .time taken in hours | — |
Countries
India
Contacts
Public ContactDr Harpreet Babrah
Government Medical College, Rajindra Hospital, Patiala.
Outcome results
None listed